Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction

NCT: NCT05870488 · ACTIVE_NOT_RECRUITING

NCT IDNCT05870488
StatusACTIVE_NOT_RECRUITING
Start Date2023-05-23
Completion2027-11
SponsorSI-BONE, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction (STACI) is a prospective, multicenter, study of SIJ fusion using the iFuse TORQ implant system.

Frequently Asked Questions

What is iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction?

iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction is a clinical trial registered under NCT05870488. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05870488?

The current status of NCT05870488 (iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction) is: ACTIVE_NOT_RECRUITING.

When did iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction start?

iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction started on 2023-05-23.

Related Devices

K213667iFuse-TORQ® Implant SystemSI-BONE, Inc. K222605iFuse TORQ® Implant SystemSI-BONE, Inc. K231689iFuse TORQ® Implant SystemSI-BONE, Inc. K241504iFuse TORQ TNT™ Implant SystemSI-BONE, Inc. K241574iFuse TORQ® Implant SystemSI-BONE, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑